# Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery

> **NCT01857921** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 290 (actual)

## Conditions studied

- Coronary Artery

## Interventions

- **DRUG:** Pravastatin 20mg/day for 12 months after randomization
- **DRUG:** Atorvastatin 40 mg and trimetazidine MR 70 mg/day for 12 months after randomization

## Key facts

- **NCT ID:** NCT01857921
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2018-04-08
- **Final completion:** 2018-04-08
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857921, "Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01857921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*